FDA Grants Regenerative Medication Superior Remedy (RMAT) designation to Autolus’ CAR T cell remedy, obe-cel, for the remedy of grownup B-ALL
Autolus Restricted LONDON, April 25, 2022 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a
Autolus